The interesting thing here is the fact that two TV news stations (KENS and KLTA) aired a segment on Mipsagargin years ago and a trial was performed where it did kill the cancer tumor, and then...nothing.
No word from Dionne, nothing can be found on the internet about him and not much about Mipsagargin either; even though INSPYR renewed the patent until 2034.
If you ask me, it seems as though G-202 is legitimate and big pharma is trying to figure out how to get this thing to market while coming up with a way to make money long-term from cancer patients.
Maybe a gag order was placed in order to complete trials on a larger scale before telling the public about its efficacy.
If that is the case, INSPYR could be looking at a major buyout or major partnership. If that happens, we'll all be able to retire yesterday.
This could also be a scam, but I like to believe it is not.
News 
Market Data 
Discover 
